E-LIB Suche - Ergebnisse für: Hayslip, John

1

Venetoclax exposure‐efficacy and exposure‐safety relationsh..:

Brackman, Deanna ; Eckert, Doerthe ; Menon, Rajeev...
Hematological Oncology. 40 (2022) 2 - p. 269-279 , 2022

Link: https://doi.org/10.1002/..

2

6-month follow-up of VIALE-C demonstrates improved and dura..:

Wei, Andrew H. ; Panayiotidis, Panayiotis ; Montesinos, Pau...
Blood Cancer Journal. 11 (2021) 10 - p. , 2021

Link: https://doi.org/10.1038/..

3

Author Correction: 6-month follow-up of VIALE-C demonstrate..:

Wei, Andrew H. ; Panayiotidis, Panayiotis ; Montesinos, Pau...
Blood Cancer Journal. 11 (2021) 10 - p. , 2021

Link: https://doi.org/10.1038/..

4

AML-062: Long-Term Follow-Up of a Phase 1/2 Study of Veneto..:

Wei, Andrew H. ; Strickland, Stephen ; Hou, Jing-Zhou...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S178 , 2020

Link: https://doi.org/10.1016/..

5

Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhib..:

de Vos, Sven ; Leonard, John P. ; Friedberg, Jonathan W....
Leukemia & Lymphoma. 62 (2020) 4 - p. 810-818 , 2020

Link: https://doi.org/10.1080/..

6

Optimizing venetoclax dose in combination with low intensiv..:

Agarwal, Suresh ; Gopalakrishnan, Sathej ; Mensing, Sven...
Hematological Oncology. 37 (2019) 4 - p. 464-473 , 2019

Link: https://doi.org/10.1002/..

7

Cytogenetic and Molecular Drivers of Outcome with Venetocla..:

Strickland, Stephen A. ; Chyla, Brenda ; Popovic, Relja...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) - p. S202 , 2018

Link: https://doi.org/10.1016/..

8

Oxidative Stress Following High Dose Chemotherapy with Auto..:

Saeed, Hayder ; Alstott, Michael C. ; Mitov, Mihail...
Biology of Blood and Marrow Transplantation. 22 (2016) 3 - p. S131-S132 , 2016

Link: https://doi.org/10.1016/..

9

Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubi..:

Hayslip, John ; Dressler, Emily V. ; Weiss, Heidi...
PLOS ONE. 10 (2015) 4 - p. e0124988 , 2015

Link: https://doi.org/10.1371/..

10

Simvastatin interacts synergistically with tipifarnib to in..:

Ahmed, Tamer A. ; Hayslip, John ; Leggas, Markos
Leukemia Research. 38 (2014) 11 - p. 1350-1357 , 2014

Link: https://doi.org/10.1016/..

11

Pharmacokinetics of high-dose simvastatin in refractory and..:

Ahmed, Tamer A. ; Hayslip, John ; Leggas, Markos
Cancer Chemotherapy and Pharmacology. 72 (2013) 6 - p. 1369-1374 , 2013

Link: https://doi.org/10.1007/..

12

A phase I study using bortezomib with weekly idarubicin for..:

Howard, Dianna S. ; Liesveld, Jane ; Phillips II, Gordon L....
Leukemia Research. 37 (2013) 11 - p. 1502-1508 , 2013

Link: https://doi.org/10.1016/..

13

Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant..:

Gul, Zartash ; Bailey, Samuel D. ; Van Meter, Emily...
Biology of Blood and Marrow Transplantation. 19 (2013) 2 - p. S199-S200 , 2013

Link: https://doi.org/10.1016/..

14

Validated LC–MS/MS method for simultaneous determination of..:

Ahmed, Tamer A. ; Horn, Jamie ; Hayslip, John.
Journal of Pharmaceutical Analysis. 2 (2012) 6 - p. 403-411 , 2012

Link: https://doi.org/10.1016/..

15

Rituximab in the treatment of B-cell non-Hodgkin lymphoma, ..:

Hayslip, John
ClinicoEconomics and Outcomes Research. , 2010

Link: https://doi.org/10.2147/..